Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
226 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (1)
  • (-) Closed (1)

Medical Condition

  • Show all (88)
  • Autoimmune Disorders (4)
  • Blood Disorders (33)
  • Cancer (1)
  • Endocrine & Metabolic Disease (1)
  • Hair and Skin Disorders (1)
  • Healthy Volunteers (3)
  • Heart Disease (1)
  • Kidney Disease (1)
  • Neurological Disorders (36)
  • Obstetrics & Gynecology (1)
  • Pediatrics (1)
  • Psychiatric Disorders (5)
    • (-) Bipolar Disorder (1)
    • Depression (3)
Displaying 1 - 1 of 1

MRI Effects of D-cycloserine & Lurasidone in Bipolar Depression

Condition: Psychiatric Disorders / Bipolar Disorder
Investigator: Joshua Kantrowitz, Md
Status: Closed
We will evaluate the D-cycloserine (DCS) and lurasidone with MRI measurement of brain responses to DCS. DCS is a drug that works on the same brain receptor as ketamine. DCS is not approved by the FDA for bipolar depression. Study participants will receive a dose of lurasidone or placebo in one MRI and a dose of DCS in another, followed by an optional follow…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science